Inspire Medical Systems, Inc. (INSP) — Analyst outlook / Analyst consensus target is. Based on 27 analyst ratings, the consensus is bullish — 13 Buy, 14 Hold.
The consensus price target is $97.50 (low: $60.00, high: $180.00), representing an upside of 71.6% from the current price $56.83.
Analysts estimate Earnings Per Share (EPS) of $1.34 and revenue of $0.80B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $1.80 vs est $1.34 (beat +34.8%). 2025: actual $4.95 vs est $1.68 (beat +194.2%). Analyst accuracy: 54%.
INSP Stock — 12-Month Price Forecast
$97.50
▲ +71.56% Upside
Average Price Target
Based on 27 Wall Street analysts offering 12-month price targets for Inspire Medical Systems, Inc., the average price target is $97.50, with a high forecast of $180.00, and a low forecast of $60.00.
The average price target represents a +71.56% change from the last price of $56.83.
Highest Price Target
$180.00
Average Price Target
$97.50
Lowest Price Target
$60.00
INSP Analyst Ratings
Hold
Based on 27 analysts giving stock ratings to Inspire Medical Systems, Inc. in the past 3 months
EPS Estimates — INSP
54%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $1.80
vs Est $1.34
▲ 25.8% off
2025
Actual $4.95
vs Est $1.68
▲ 66.0% off
Profitability Outlook
Company is profitable with solid earnings. EPS trend is improving.
Revenue Estimates — INSP
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.803B
vs Est $0.800B
▲ 0.4% off
2025
Actual $0.912B
vs Est $0.909B
▲ 0.4% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
